Dr. Reddy's Laboratories Ltd. (RDY) Announces the Launch of Metoprolol Succinate ER (Extended-Release) Tablets  
9/11/2012 10:12:37 AM

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE: RDY) announced today that is has launched Metoprolol Succinate ER (Extended-Release) Tablets (25 mg, 50 mg, 100 mg & 200 mg), a bioequivalent generic version of Toprol-XL® (Metoprolol Succinate) Tablets in the US market on September 10, 2012. Metoprolol ER (Extended-Release) Tablets (25 mg, 50 mg, 100 mg, & 200 mg) was approved by the United States Food & Drug Administration (USFDA) in August 2012.